# Broad-spectrum Antibiotic Prophylaxis in Tumor and Infected Orthopedic Surgery

> **NCT05502380** · PHASE3 · RECRUITING · sponsor: **Balgrist University Hospital** · enrollment: 1100 (estimated)

## Conditions studied

- Surgical Site Infection
- Microbial Colonization
- Antibiotic Resistant Infection

## Interventions

- **DRUG:** Standard antibiotic prophylaxis

## Key facts

- **NCT ID:** NCT05502380
- **Lead sponsor:** Balgrist University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-15
- **Primary completion:** 2024-12-12
- **Final completion:** 2025-12-12
- **Target enrollment:** 1100 (ESTIMATED)
- **Last updated:** 2024-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05502380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05502380, "Broad-spectrum Antibiotic Prophylaxis in Tumor and Infected Orthopedic Surgery". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05502380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*